phil_vardena

Hansen Medical: A Stock to Make Any Investor's Heart Happy

And what about the 8% drop the day follwing that?


On Nov 12 07:15 PM Jason Kelly wrote:

> Uh, gang: read a little more carefully next time, and note the abundance
> of sarcasm. Note, too, the position disclosure.
>
> The article was partially tongue-in-cheek to show that even cooked
> books can't keep a stock down in this environment. The one-day 18%
> pop following the posting proved the point.

Hansen Medical: A Stock to Make Any Investor's Heart Happy

Author, you did not do your dd.

HNSN has a bad safety profile. We know of at least one death, but we also know that HNSN under reports its safety accidents. They have a 4-8 % safety issues overall, depending on the ability of the clinician - in line with manual ablations. So, if results are in line, why switch to robotics?

STXS has an excellent safety profile. They have done many more cases and their accident rate is 0.1%, with no deaths. Learning curve is favourable and even if the clinician makes a mistake, the floppy catheter is not able to perforate the cardiovascular system.

Scientific literature is 20 to 1 STXS vs. HNSN. Leader clinicians around the world are endorsing STXS and dumping HNSN.

Just take a look at how many senior managers left their jobs at HNSN during the last year or so and ask yourself why?

Your puff piece about HNSN is so inaccurate it is beyond any comment.

A last one. Just because their share price collapsed from 30 to 3, it does not mean they will see 30 ever again.

No, the last one is that HNSN does NOT have approval to treat any kind of arrythmias, they have FDA approval for mapping only. When the clinician uses Sensei for ablations they do so off-label; while STXS has everything FDA approved for ablations...

I expect the FDA to step in and close HNSN down for good anytime.

I am long STXS...

6 Medical Device Makers Poised for Growth

You say that "HNSN has received FDA approval". That's true for mapping, but not true for anything else. The use of Sensei as a tool for cardiac ablation is "off label" and open to lawsuits.

Also your statement "Among the medical community, it is believed that the Sensei system is better, as well as being cheaper" is ambiguous. "Medical community". Look, the HRS 2008 starts in a few days. 90% of core abstracts revolve around the use of Remote Magnetical Navigation devices, which means Niobe, which means Stereotaxis. Is the Sensei better? Simple math doesn't say so.

Adverse effects with Stereotasis' Niobe represents less than 0.1% of 15,000 procedures.
Sensei gets something north of 6%. Is the Sensei better? I wouldn't undergo a procedure with Sensei even if well paid!

Regards,
phil